501.64MMarket Cap
LossP/E TTM
Valneva SE's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Valneva SE is 8.35, ranking 144 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.86, which is -4702.27% below the recent high of 177.67 and -2952.47% above the recent low of -117.84.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.